A new poll by the Pew Research Center shows that the percentage of American adults who will get the new coronavirus vaccine has dropped to just 51 percent. 24 percent were adamant that they will definitely not get the new vaccine, while another 25 percent answered that they will probably not take the new vaccine, when it is approved.

Just about half of U.S. adults (51 percent) now say they would definitely or probably get a vaccine to prevent COVID-19 if it were available today. The percentage who would get the vaccine if it was available has fallen dramatically from the 72 percent who answered that they would take it back in May.

The share who say that they would definitely get a coronavirus vaccine has now dropped to just 21 percent, down from 42 percent in May. 30 percent answered that they would probably take the vaccine.

The vaccine is more popular with Democrats than Republicans; but those willing to get vaccinated has dropped among all demographics. Just 17 percent of those who identify as being Republican or leaning Republican say that they will definitely get the vaccine versus 24 percent for Democrats or lean Democrat. 30 percent of Republicans and 18 percent of Democrats answered that they will definitely not get the vaccine if it were available, this is up from 15 percent and 8 percent in May.

56 percent of men answered that they will definitely or probably get vaccinated; while just 49 percent of women. 52 percent of Whites will definitely or probably get vaccinated; while just 32 percent of Blacks (the demographic which generally has the worst COVID-19 outcomes) responded that they will get the vaccine. 71 percent of Asians and 56 percent of Hispanics say that they will definitely or probably get the vaccine.

57 percent of those who are planning to get a vaccine say that they would be a little (36 percent) or a lot (21 percent) less likely to do so if they had to pay for it themselves. 42 percent said that out-of-pocket costs would not change their likelihood of getting the vaccine.

Public health officials worry that if less than half of the population even gets vaccinated then herd health immunity will not be achieved through vaccination and the coronavirus could continue to spread,

Public Service Announcement

The new national survey by the Pew Research Center was conducted between September 8 to 13 among 10,093 U.S. adults.

Meanwhile on Wednesday Johnson & Johnson announced that they have begun the third and final phase of vaccination trials. 60,000 people age 18 and over are participating in five countries, including the U.S.

Pfizer, Moderna, and AstraZeneca meanwhile have been in Phase 3 trials for months now and have suggested they may have enough data to know whether their vaccines are safe and effective by October or November of this year. AstraZeneca suspended their trials in the U.S. after the early results showed some side effect issues; though those trials have resumed.

ADVERTISEMENT

The Johnson & Johnson vaccine is a one shot vaccine; while the other three require a second booster shot doubling the logistics issues with mass vaccination.

President Donald J. Trump (R) has said that the vaccine could be available at that time; but the Director of the Center for Disease Control and Prevention Robert Redfield has scoffed at that and said that a vaccine will not be ready until the middle of next year.

White House Coronavirus Task Force member Dr. Anthony Fauci testified to Congress on Wednesday that vaccine production is already underway so that if one of the four companies in trials now receive FDA approval ramp up time to full production will be minimal.

Redfield told Congress this week that the CDC urgently needs $6 billion for COVID-19 vaccine distribution efforts.

Globally 982,513 people, including 206,598 Americans, have died from COVID-19 and over 32 million people globally have been diagnosed with the coronavirus, including 7,140,137 Americans.